相似文献
1
Interferon and its inducers--a never-ending story: "old" and "new" data in a new perspective.
J Infect Dis. 2006 Sep 15;194 Suppl 1(Suppl 1):S19-26. doi: 10.1086/505351.
2
[Proceedings: Current prospects in antiviral chemotherapy].
Minerva Med. 1973 Nov 3;64(78):4100-6.
3
Evaluation of interferon and interferon inducers as antiviral agents: animal studies.
Pharmacol Ther. 1981;13(1):1-38. doi: 10.1016/0163-7258(81)90065-6.
4
Results and prospects of virus chemotherapy.
Ther Hung. 1973;21(2):51-5.
5
[Interferon].
Rev Invest Clin. 1981 Oct-Dec;33(4):419-25.
6
[Interferon and its inducers].
Rev Prat. 1979 Aug;29(37):2929-33.
7
[The interferon and the antiviral defense].
An R Acad Nac Med (Madr). 2006;123(2):321-39; discussion 340-5.
8
[Interferon: its effects and clinical application].
Internist (Berl). 1978 Dec;19(12):659-63.
9
[Interferon and so-called interferon inducers].
Wien Klin Wochenschr. 1973 Jun 29;85(26):461-6.
10
[The medical significance of interferons and their inducers].
Vestn Ross Akad Med Nauk. 2004(2):9-13.
引用本文的文献
1
Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder Lines.
Viruses. 2024 Oct 17;16(10):1625. doi: 10.3390/v16101625.
2
Swine NONO promotes IRF3-mediated antiviral immune response by Detecting PRRSV N protein.
PLoS Pathog. 2024 Oct 16;20(10):e1012622. doi: 10.1371/journal.ppat.1012622. eCollection 2024 Oct.
3
Emerging Technologies for the Treatment of COVID-19.
Adv Exp Med Biol. 2021;1321:81-96. doi: 10.1007/978-3-030-59261-5_7.
4
An aberrant STAT pathway is central to COVID-19.
Cell Death Differ. 2020 Dec;27(12):3209-3225. doi: 10.1038/s41418-020-00633-7. Epub 2020 Oct 9.
5
Conservation of cell-intrinsic immune responses in diverse nonhuman primate species.
Life Sci Alliance. 2019 Oct 24;2(5). doi: 10.26508/lsa.201900495. Print 2019 Oct.
6
Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects.
J Control Release. 2018 Apr 10;275:53-66. doi: 10.1016/j.jconrel.2018.02.012. Epub 2018 Feb 9.
7
Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus Suppresses Both MAVS and RIG-I Expression as One of the Mechanisms to Antagonize Type I Interferon Production.
PLoS One. 2016 Dec 20;11(12):e0168314. doi: 10.1371/journal.pone.0168314. eCollection 2016.
8
Regioselective synthesis of 6-substituted-2-amino-5-bromo-4(3H)-pyrimidinones and evaluation of their antiviral activity.
Eur J Med Chem. 2013 Sep;67:428-33. doi: 10.1016/j.ejmech.2013.06.036. Epub 2013 Jul 5.
9
Mosquito RNAi is the major innate immune pathway controlling arbovirus infection and transmission.
Future Microbiol. 2011 Mar;6(3):265-77. doi: 10.2217/fmb.11.11.
10
Modulation of host cell responses and evasion strategies for porcine reproductive and respiratory syndrome virus.
Virus Res. 2010 Dec;154(1-2):48-60. doi: 10.1016/j.virusres.2010.07.019. Epub 2010 Jul 23.
本文引用的文献
1
Pillars Article: Virus Interference. I. The Interferon. Proc R Soc Lond B Biol Sci. 1957. 147: 258-267.
J Immunol. 2015 Sep 1;195(5):1911-20.
2
Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.
Expert Rev Anti Infect Ther. 2003 Jun;1(1):21-43. doi: 10.1586/14787210.1.1.21.
3
Antivirals and antiviral strategies.
Nat Rev Microbiol. 2004 Sep;2(9):704-20. doi: 10.1038/nrmicro975.
4
Discovery of antivirals against smallpox.
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11178-92. doi: 10.1073/pnas.0403600101. Epub 2004 Jul 12.
5
Immunology. After the toll rush.
Science. 2004 Mar 5;303(5663):1481-2. doi: 10.1126/science.1096113.
6
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.
Ann Intern Med. 2004 Mar 2;140(5):346-55. doi: 10.7326/0003-4819-140-5-200403020-00010.
7
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.
Nat Med. 2004 Mar;10(3):290-3. doi: 10.1038/nm1001. Epub 2004 Feb 22.
8
The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis.
Antimicrob Agents Chemother. 2004 Jan;48(1):267-74. doi: 10.1128/AAC.48.1.267-274.2004.
9
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
Clin Microbiol Rev. 2003 Oct;16(4):569-96. doi: 10.1128/CMR.16.4.569-596.2003.
10
Interferon-beta in the treatment of relapsing-remitting multiple sclerosis.
Pharmacol Ther. 2003 Oct;100(1):49-62. doi: 10.1016/s0163-7258(03)00085-8.
Zotero 插件